Sort by
Refine Your Search
-
Category
-
Program
-
Employer
- RCSI - Royal College of Surgeons in Ireland
- University College Dublin
- University of Galway
- MAYNOOTH UNIVERSITY
- South East Technological University
- University College Cork
- ;
- Centre for Synthesis & Chemical Biology, University College Dublin
- Dublin City University
- Maynooth University
- NIBRT
- Trinity College Dublin
- UCD
- University of Dublin, Trinity College
- 4 more »
- « less
-
Field
-
of antimicrobial resistance. This new project complements other research in our lab. The Byrne Group is a growing bioinorganic chemistry research group that targets carbohydrate-protein interactions to build new
-
, etc. *Knowledge of Bayesian inference and sensor fusion. *Demonstrated ability to write peer-reviewed scientific manuscripts. *Knowledge in Dockerisation, Kubernetes, Django and Geoserver. *Some
-
Medical's ECORE technology, the world's first vessel-agnostic embolisation technology, which achieves complete vessel occlusion while allowing targeted distal therapeutic delivery. The core purpose of
-
is focused on development of novel therapies for metastatic breast cancer (Róisín Dwyer - University of Galway). This project will specifically investigate the potential of microRNAs as targeted
-
remodelling. Current therapies are ineffective, targeting the repair phase, but non-healing is associated with altered macrophage (Mφ) phenotype and inflammation. A potent regulator of repair is mechanical
-
clinical research to deliver transformational, high impact changes in health care. Targeting both Irish national and EU funding, along with increased collaboration with industry, is a major part of the RCSI
-
the UN Sustainable Development Goals – with a particular focus on Goal 3, which targets good health and well-being. For each of the last six years, RCSI has been positioned in the Top 300 of universities
-
the genes expressed in a cell or to activate the expression of silent genes. The advantage is that it is relatively unbiased and has the potential to target every gene in the genome. Aims and Objectives: In
-
protein targets for in-house compounds active on an incurable lung cancer. Scholarship Benefits This is a very well-funded project, including a €25,000 annual stipend, fees, consumables, high-end PC, >€4000
-
Centre for Synthesis & Chemical Biology, University College Dublin | Dublin Bar, Leinster | Ireland | about 1 month ago
materials for the production of high value pharmaceutical targets. To achieve this, chemical entities will be identified that have the capacity to cause the most abundant and readily available functionalised